爱康医疗发布中期业绩 股东应占溢利1.61亿元 同比增加15.34%

Group 1 - The core viewpoint of the article is that Aikang Medical (01789) reported a mid-term performance for the six months ending June 30, 2025, showing a revenue of 694 million RMB, which represents a year-on-year increase of 5.65% [1] - The company's profit attributable to shareholders reached 161 million RMB, reflecting a year-on-year increase of 15.34% [1] - The basic earnings per share for the company were reported at 0.14 RMB [1]